Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Resurrection of uric acid as a causal risk factor in essential hypertension.
Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH. Johnson RJ, et al. Hypertension. 2005 Jan;45(1):18-20. doi: 10.1161/01.HYP.0000150785.39055.e8. Epub 2004 Nov 22. Hypertension. 2005. PMID: 15557387 No abstract available.
Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.
Johnson RJ, Rodriguez-Iturbe B, Nakagawa T, Kang DH, Feig DI, Herrera-Acosta J. Johnson RJ, et al. Hypertension. 2005 Mar;45(3):326-30. doi: 10.1161/01.HYP.0000154784.14018.5f. Epub 2005 Jan 17. Hypertension. 2005. PMID: 15655117 Review. No abstract available.
How does angiotensin II cause renal injury?
Long DA, Price KL, Herrera-Acosta J, Johnson RJ. Long DA, et al. Hypertension. 2004 Apr;43(4):722-3. doi: 10.1161/01.HYP.0000120964.22281.3e. Epub 2004 Feb 16. Hypertension. 2004. PMID: 14967828 No abstract available.
Diuretic-induced hyperuricemia does not decrease cardiovascular risk.
Srinivas TR, Herrera-Acosta J, Feig DI, Kang DH, Segal MS, Johnson RJ. Srinivas TR, et al. J Hypertens. 2004 Jul;22(7):1415-7; author reply 1417-9. J Hypertens. 2004. PMID: 15201561 No abstract available.
Hormonal and cytokine effects of uric acid.
Sánchez-Lozada LG, Nakagawa T, Kang DH, Feig DI, Franco M, Johnson RJ, Herrera-Acosta J. Sánchez-Lozada LG, et al. Among authors: herrera acosta j. Curr Opin Nephrol Hypertens. 2006 Jan;15(1):30-3. doi: 10.1097/01.mnh.0000199010.33929.7f. Curr Opin Nephrol Hypertens. 2006. PMID: 16340663 Review.
A single pathway for the development of essential hypertension.
Kanellis J, Nakagawa T, Herrera-Acosta J, Schreiner GF, Rodríguez-Iturbe B, Johnson RJ. Kanellis J, et al. Cardiol Rev. 2003 Jul-Aug;11(4):180-96. doi: 10.1097/01.CRD.0000077361.00668.14. Cardiol Rev. 2003. PMID: 12852795 Review. No abstract available.
A causal role for uric acid in fructose-induced metabolic syndrome.
Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. Nakagawa T, et al. Among authors: herrera acosta j. Am J Physiol Renal Physiol. 2006 Mar;290(3):F625-31. doi: 10.1152/ajprenal.00140.2005. Epub 2005 Oct 18. Am J Physiol Renal Physiol. 2006. PMID: 16234313 Free article.
Uric acid--a uremic toxin?
Nakagawa T, Mazzali M, Kang DH, Sánchez-Lozada LG, Herrera-Acosta J, Johnson RJ. Nakagawa T, et al. Among authors: herrera acosta j. Blood Purif. 2006;24(1):67-70. doi: 10.1159/000089440. Blood Purif. 2006. PMID: 16361844 Free article. Review.
A unifying pathway for essential hypertension.
Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J. Johnson RJ, et al. Am J Hypertens. 2005 Mar;18(3):431-40. doi: 10.1016/j.amjhyper.2004.08.035. Am J Hypertens. 2005. PMID: 15797666 Review.
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Johnson RJ, et al. Hypertension. 2003 Jun;41(6):1183-90. doi: 10.1161/01.HYP.0000069700.62727.C5. Epub 2003 Apr 21. Hypertension. 2003. PMID: 12707287 Review.
107 results
Jump to page
Feedback